ASN892713_Supplemental_Material.pdf (44.94 kB)
0/0

ASN892713 Supplemental Material - Supplemental material for Chemotherapeutic Effect of SR9009, a REV-ERB Agonist, on the Human Glioblastoma T98G Cells

Download (44.94 kB)
journal contribution
posted on 12.12.2019 by Paula M. Wagner, Natalia M. Monjes, Mario E. Guido

Supplemental material, ASN892713 Supplemental Material for Chemotherapeutic Effect of SR9009, a REV-ERB Agonist, on the Human Glioblastoma T98G Cells by Paula M. Wagner, Natalia M. Monjes and Mario E. Guido in ASN Neuro

Funding

ANPCyT FONCyT

History

Exports